Erythrocyte aggregation in clinical medicine.

Area of Science:

• Hematology
• Physiology
• Biomedical Engineering

Background:

• Red cell aggregation is a key blood property affecting microcirculatory blood flow.
• Increased erythrocyte aggregation contributes to blood viscosity and maldistribution of flow, impairing tissue oxygen transport.
• Elevated red cell aggregation is observed in numerous diseases and linked to clinical symptoms.

Purpose of the Study:

• To explore the role of red cell aggregation in impaired microcirculation.
• To discuss the implications of red cell aggregation on blood flow and oxygen delivery.
• To highlight the potential therapeutic benefits of reducing red cell aggregation.

Main Methods:

• Review of existing literature on red cell aggregation and microcirculation.
• Analysis of disease states associated with increased red cell aggregation.
• Consideration of therapeutic interventions targeting red cell aggregation.

Main Results:

• Red cell aggregation negatively influences blood viscosity and flow distribution.
• Therapeutic interventions like plasmapheresis and defibrinogenation show benefit by reducing aggregation.
• Reducing red cell aggregation is a potential strategy to improve microcirculatory blood flow and oxygen supply.

Conclusions:

• Red cell aggregation plays a critical role in microcirculatory dysfunction and reduced tissue oxygenation.
• Targeting red cell aggregation with desaggregating drugs offers a promising therapeutic avenue.
• Differentiating the precise impact of red cell aggregation versus plasma viscosity remains challenging due to their interconnectedness.